Amiel Segal
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- PARP inhibition in cancer therapy
Papers in
- Oncology 7
- Pancreatic and Hepatic Oncology Research 6
-
- Cancer Genomics and Diagnostics 4
- Co-authors
- Earl R. Stadtman (3 shared papers)Martin Flavin (1 shared paper)Talia Golan (7 shared papers)Raphael Catane (3 shared papers)Nathan I. Cherny (3 shared papers)Yuri Goldes (3 shared papers)Elina Zorde Khvalevsky (3 shared papers)Ayala Hubert (3 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)The Journal of Urology (3 papers)Archives of Biochemistry and Biophysics (3 papers)Anti-Cancer Drugs (2 papers)European Journal of Cancer (1 paper)
- Partner nations
- United StatesIsraelCanada
In The Last Decade
Amiel Segal
21 papers receiving 773 citations
Peers
Comparison fields: 5 of 80
- Cancer Research 204
- Oncology 271
- Biochemistry 70
- Gastroenterology 34
- Molecular Biology 337
Countries citing papers authored by Amiel Segal
This map shows the geographic impact of Amiel Segal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amiel Segal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amiel Segal more than expected).
Fields of papers citing papers by Amiel Segal
This network shows the impact of papers produced by Amiel Segal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amiel Segal. The network helps show where Amiel Segal may publish in the future.
Co-authors
The 25 scholars most cited alongside Amiel Segal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 266 | |
| 2 | 2017 | 124 | |
| 3 | 2000 | 99 | |
| 4 | 1964 | 51 | |
| 5 | 2017 | 39 | |
| 6 | 2004 | 34 | |
| 7 | 2014 | 30 | |
| 8 | 1972 | 29 | |
| 9 | 1977 | 26 | |
| 10 | 1974 | 24 | |
| 11 | 2013 | 19 | |
| 12 | 1972 | 17 | |
| 13 | 2010 | 9 | |
| 14 | 2015 | 8 | |
| 15 | 2013 | 7 | |
| 16 | 1998 | 7 | |
| 17 | 2012 | 5 | |
| 18 | 2014 | 3 | |
| 19 | 2012 | 2 | |
| 20 | 1989 | 2 |
About Amiel Segal
Amiel Segal is a scholar working on Oncology, Cancer Research, Surgery, Biochemistry and Pediatrics, Perinatology and Child Health, having authored 21 papers that have together received 802 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (6 papers), Cancer Genomics and Diagnostics (4 papers), Amino Acid Enzymes and Metabolism (3 papers), Gastrointestinal disorders and treatments (3 papers), Intestinal and Peritoneal Adhesions (2 papers), Pediatric Urology and Nephrology Studies (2 papers), Urological Disorders and Treatments (2 papers) and Enzyme Structure and Function (2 papers). The work is most often cited by research in Cancer Research (204 citations), Oncology (271 citations), Biochemistry (70 citations), Gastroenterology (34 citations) and Molecular Biology (337 citations). Amiel Segal has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include Earl R. Stadtman, Martin Flavin, Talia Golan, Raphael Catane, Nathan I. Cherny, Yuri Goldes, Elina Zorde Khvalevsky, Ayala Hubert, Eliel Ben-David and Amotz Shemi. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Urology, Archives of Biochemistry and Biophysics, Anti-Cancer Drugs and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.